Page last updated: 2024-08-23

brimonidine tartrate and inositol 1,4,5-trisphosphate

brimonidine tartrate has been researched along with inositol 1,4,5-trisphosphate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Feijge, MA; Heemskerk, JW; Keularts, IM; van Gorp, RM; Vuist, WM	1
Alpini, G; Francis, H; Glaser, S; Kanno, N; Lesage, G; Phinizy, JL	1

Other Studies

2 other study(ies) available for brimonidine tartrate and inositol 1,4,5-trisphosphate

Article	Year
alpha(2A)-adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels. The Journal of biological chemistry, 2000, Jan-21, Volume: 275, Issue:3 Topics: Adrenergic alpha-Agonists; Aspirin; Blood Platelets; Brimonidine Tartrate; Calcium; Calcium Chloride; Carbazoles; Cyclic AMP; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Inhibitors; Epinephrine; Humans; Indoles; Inositol 1,4,5-Trisphosphate; Models, Biological; Phosphorylation; Platelet Activating Factor; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Prostaglandins E; Pyrroles; Quinoxalines; Receptors, Adrenergic, alpha-2; Stimulation, Chemical; Thapsigargin; Thimerosal; Thrombin; Time Factors	2000
Stimulation of alpha2-adrenergic receptor inhibits cholangiocarcinoma growth through modulation of Raf-1 and B-Raf activities. Hepatology (Baltimore, Md.), 2002, Volume: 35, Issue:6 Topics: Adrenergic alpha-Agonists; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Blotting, Western; Brimonidine Tartrate; Cell Division; Cholangiocarcinoma; Cyclic AMP; Humans; Inositol 1,4,5-Trisphosphate; MAP Kinase Signaling System; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-raf; Quinoxalines; ras Proteins; Receptors, Adrenergic, alpha-2; Tumor Cells, Cultured	2002

Article

Year

alpha(2A)-adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels.

The Journal of biological chemistry, 2000, Jan-21, Volume: 275, Issue:3

Topics: Adrenergic alpha-Agonists; Aspirin; Blood Platelets; Brimonidine Tartrate; Calcium; Calcium Chloride; Carbazoles; Cyclic AMP; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Inhibitors; Epinephrine; Humans; Indoles; Inositol 1,4,5-Trisphosphate; Models, Biological; Phosphorylation; Platelet Activating Factor; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Prostaglandins E; Pyrroles; Quinoxalines; Receptors, Adrenergic, alpha-2; Stimulation, Chemical; Thapsigargin; Thimerosal; Thrombin; Time Factors

2000

Stimulation of alpha2-adrenergic receptor inhibits cholangiocarcinoma growth through modulation of Raf-1 and B-Raf activities.

Hepatology (Baltimore, Md.), 2002, Volume: 35, Issue:6

Topics: Adrenergic alpha-Agonists; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Blotting, Western; Brimonidine Tartrate; Cell Division; Cholangiocarcinoma; Cyclic AMP; Humans; Inositol 1,4,5-Trisphosphate; MAP Kinase Signaling System; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-raf; Quinoxalines; ras Proteins; Receptors, Adrenergic, alpha-2; Tumor Cells, Cultured

2002